Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Choosing the right investment app can be daunting for beginners. We break down the best options to help you start investing confidently.
24,582 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Amundi, Europe's biggest asset manager, launches a UCITS-compliant Solana fund in partnership with SPiko Finance, mar...
SpaceX outlines a bold public listing to finance lunar and Martian programs, as markets evaluate the risk of big loss...
A disciplined approach to a small Bitcoin allocation could unlock a longer retirement runway. This guide explains how...
A draft framework for ending the war between Iran and the U.S. appears close to finalization, with Hormuz talks inclu...
As shoppers stretch budgets, investors wonder: is walmart stock still safe? This deep dive examines Walmart's defensi...
Oil trades near $96 a barrel as investors parse OPEC plans and demand signals. The current price 2026 landscape remai...
Analysts see a path for Intel to reach higher stock levels by 2028 if its foundry expansion and AI data-center moment...
Weibo's Q1 2026 earnings transcript reveals a steady growth path with ad-driven strength and improving non-ad monetiz...
A clash over 401(K) defaults intensifies as Suze Orman questions age-based glide paths and new needs-based approaches...
President Trump taps Bill Pulte to serve as Acting Director of National Intelligence while keeping him at the helm of...
A California crypto executive dubbed 'The Godfather' pleads guilty to conspiring in a scheme tied to a $245 million b...